title: [Prescription of rimonabant in the early stage of pregnancy?].
abstract: Rimonabant should not be prescribed in pregnancy because no sufficient data on the teratogenic/ embryotoxic risk are available. A preventive termination of pregnancy is not indicated. Women in childbearing age should take only low-risk drugs. Otherwise dedicated information, in doubt pregnancy test, and strict contraception is required.
authors.affiliation: Zentralapotheke, Medizinische Hochschule Hannover, 30623 Hannover. Picksak.Gesine@mh-hannover.de
authors.forename: Gesine
authors.initials: G
authors.lastname: Picksak
authors.forename: Dirk O
authors.initials: DO
authors.lastname: Stichtenoth
mesh_terms: D000328:Adult; D019440:Anti-Obesity Agents / Q000009:adverse effects* / Q000627:therapeutic use; D063387:Cannabinoid Receptor Antagonists; D005260:Female; D006801:Humans; D010880:Piperidines / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy / Q000502:physiology*; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000077285:Rimonabant
chemical_list: D019440:Anti-Obesity Agents; D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant